Cargando…
Study of Clinical Outcome and Healthcare Modalities of COVID-19 Patients Treated With Remdesivir at a Tertiary Care Teaching Hospital
Background Effective treatment for COVID-19 infection is still under evaluation. Remdesivir is an approved drug for COVID-19 treatment and major countries have released guidelines on the use of remdesivir. Still, many factors are under evaluation which can determine the future use of remdesivir. Aim...
Autores principales: | Acharya, Tejas A, Joshi, Krupal J, Patel, Divyesh D, Shah, Shyam N, Mehta, Dimple S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788920/ https://www.ncbi.nlm.nih.gov/pubmed/35106259 http://dx.doi.org/10.7759/cureus.21535 |
Ejemplares similares
-
COVID-19 Infection Among Healthcare Workers at a Tertiary Healthcare Hospital
por: Abdul Muthalib, Hamna, et al.
Publicado: (2023) -
Cost–utility analysis of antimicrobial stewardship programme at a tertiary teaching hospital in Ethiopia
por: Gebretekle, Gebremedhin Beedemariam, et al.
Publicado: (2021) -
Appropriateness of Surgical Antibiotic Prophylaxis in a Tertiary Care Teaching Hospital in Central India: A Retrospective Analysis
por: Gurunthalingam, Meenalotchini P, et al.
Publicado: (2023) -
Clinical use of remdesivir in COVID-19 treatment: a retrospective cohort study
por: Pham, Hong Tham, et al.
Publicado: (2023) -
Bacterial Isolates and Their Antimicrobial Susceptibility Profile in Osteomyelitis Patients: An Experience From a Tertiary Care Center in a Hilly Area of Uttarakhand
por: Raina, Dimple, et al.
Publicado: (2023)